Adherence to clinical guidance in the prescribing of oral antithrombolic medication in patients with atrial fibrillation

Irish Journal of Medical Science

Volumn 175, Issue 2, 2006, Pages 46-49

  Savage, M ^a   Teeling, Mary ^a   Bennett, K ^a   Feely, J ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; DIGOXIN; DIPYRIDAMOLE; WARFARIN;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCRIPTION; STATISTICAL ANALYSIS;

EID: 33745918609     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03167949     Document Type: Article

References (19)

1. Lip GYH, Hart RG, Conway DSG. ABC of antithrombotic therapy. Antithrombotic therapy for atrial fibrillation. BMJ 2002; 325: 1022-5.
2. Albers GW, Dalen JE, Laupacis A, Manning WJ, Peterson P, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest 2001; 119: S194-S206.
3. Rockson SG, Albers GW. Comparing the guidelines: Anticoagulation therapy to optimise stroke prevention inpatients with atrial fibrillation. J Am Coll Cardiol 2004; 43(6): 929-935
4. Deplanque D, Leys D, Parnetti L et al. Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results ofthe SAFE II study. Br J Clin Pharmacol 2004; 57(6): 798-806
5. McCormick D, Gurwitz JH, Goldberg RJ et al. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med 2001; 161(20): 2458-2463
6. Fang MC, Stafford RS, Ruskin JN, Singer DE. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med 2004; 164 (1):55-60.
7. Oral anticoagulants. In: British National Formulary [50th Edition]. British Medical Association and Royal Pharmaceutical Society of Great Britain, London 2005: 123-4
8. Gage BF, Boechler M, Doggette AL et al. Adverse Outcomes and Predictors of Underuse of Antithrombotic Therapy in Medicare Beneficiaries with Chronic Atrial Fibrillation. Stroke 2000; 31: 822-7
9. Fuller R, Dudley N, Blacktop J. Avoidance hierarchies and preferences for anticoagulation - semi-qualitative analysis of older patients' views about stroke prevention and the use of warfarin. Age Ageing 2004; 33 (6): 608-11
10. Howitt A, Armstrong D. Implementing evidence based medicine in general practice: Audit and qualitative study of antithrombotic treatment for atrial fibrillation. BMJ 1999; 318: 1324-1327.
11. Protheroe J, Fahey T, Montgomery AA, Peters TJ. The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis. BMJ 2000; 320: 1380-1384.
12. Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Perera R, Meats E, Glasziou P. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006; 367: 404-11.
13. White S, Feely J, O'Neill D. Community-based Study of Atrial Fibrillation and Stroke Prevention. Ir Med J 2004; 97(1): 10-12.
14. Devereaux PJ, Anderson DR, Gardner MJ et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ 2001; 323: 1-7
15. Choudhry N, Anderson G, Laupacis A, Ross-Degnan D, Normand S, Soumerai S. Impact of adverse events on prescribing of warfarin in patients with atrial fibrillation: matched pair analysis. BMJ 2006; 332: 141-3
16. Brophy MT, Snyder KE, Gaehde S, Ives C, Gagnon D, Fiore LD. Anticoagulant use for Atrial Fibrillation in the Elderly J Am Geriatr Soc 2004; 52: 1151-1156.
17. McCormick D, Gurwitz JH, Goldberg PJ, Ansell J. Long-Term Anticoagulation Therapy for Atrial Fibrillation in Elderly Patients: Efficacy, Risk, and Current Patterns of Use. J Thromb Thrombolysis 1999; 7: 157-163.
18. Fihn SD, Callahan CM, Martin DC, McDonell MB, Henikoff JG, White RH. The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin. Ann Intern Med 1996; 124: 970-979.
19. Oswald N, Bateman H. Treating individuals according to evidence: why do primary care practitioners do what they do? J Eval Clin Pract 2002; 6(2): 139-148.